News

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Discover why now isn't the time to ...
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
Texas Attorney General Ken Paxton alleged that Lilly offered illegal incentives to medical providers in Texas designed to ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?